DLDong Liu

Dong Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dong Liu has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anti-Helicobacter pylori Activity and Gastroprotective Effects of Miao Sour Soup-Derived Lactiplantibacillus plantarum SHY0008

    by Zhaoxu Ren, Shiqi Xiao, Zixin Zhang, Feiyang Wang, Qingfang Kong, Yanhui Li, Chunxu Xue, Dong Liu, Haiyan Sun

    Helicobacter pylori (H. pylori) infection is a major global gastrointestinal health concern, and increasing antibiotic resistance has prompted interest in complementary probiotic strategies. In this study, Lactiplantibacillus plantarum SHY0008 isolated from Miao sour soup was evaluated using integrated in vitro, AGS cell, zebrafish, murine, and genomic approaches. SHY0008 showed favorable gastrointestinal tolerance, with an acid survival rate of 39.61 ± 1.87% after 4 h under simulated gastric conditions and a relative viable recovery of 64.20 ± 6.48% after 4 h of exposure to 0.3% oxgall. SHY0008 also produced inhibition zones of 17.56 ± 0.58 mm and 17.21 ± 0.29 mm for viable and heat-treated/sonicated bacterial preparations, respectively, and reduced the H. pylori urease-associated phenol-red response by 54.23 ± 3.98%. In AGS cells, SHY0008 showed an adhesion rate of 17.53 ± 1.01% and reduced the urease-associated H. pylori adhesion signal by 48.27 ± 2.52%. In a prophylactic zebrafish model, SHY0008 pretreatment was associated with reduced intestinal H. pylori-associated fluorescence and histopathological injury following subsequent exposure. In mice, SHY0008 reduced gastric H. pylori-associated antigen and urease signals, lowered serum CXCL1/KC, and improved gastric histopathology. Whole-genome analysis identified plantaricin-associated genes, while preliminary genome-based safety screening detected no known acquired antimicrobial resistance genes or virulence-associated determinants. Collectively, these findings support SHY0008 as a promising food-derived probiotic candidate with complementary anti-H. pylori and gastroprotective activities.

  • Open Access

    Genus-Level Stepwise Evolutionary Trajectories Driving the Ecological Adaptation and Epidemic Success of Acinetobacter baumannii

    by Chun-Xu Xue, Tingting Xu, Jialong Liu, Yao Xiao, Jinquan Liu, Edward J. Feil, Haiyan Sun, Dong Liu, Kai Zhou

    Background: The Acinetobacter genus encompasses numerous species occupying diverse habitats, with several emerging as human pathogens posing significant threats. However, the mechanisms underlying the emergence remain elusive. We aimed to elucidate the genomic and ecological mechanisms underlying diversification within the genus Acinetobacter and the epidemic success of A. baumannii.Methods: We conducted a large-scale population genomic analysis of Acinetobacter in the context of One Health. Habitat-switching frequency and transfer direction were inferred using ancestral state reconstruction. Ancestral genome size reconstruction and selection efficacy estimation were performed to identify the driving forces underlying inter-lineage differences. Network analyses and gene flow analysis were done to understand the genetic structure and evolutionary dynamics. Phenotypic tests were performed to assess the isolates’ physiological traits. In-frame deletion mutants were constructed to determine the function of key genetic factors identified by selection analysis.Findings: Through a genus-wide population genomic analysis, we revealed significant phylogenetic clustering of hosts coupled with distinct habitat-switching profiles, delineating two predominant lineages: an animal-associated lineage (C1) and a human-associated lineage (C2). C2 includes major clinically important pathogens, notably the A. calcoaceticus-baumannii (ACB) complex. Genome reduction driven by relaxation of selection in C1 represents a primary driver of this phylogenetic diversification, resulting in significantly smaller genomes compared to C2. This divergent genome evolution remodeled metabolic profiles, enabling C2 to utilize a markedly broader spectrum of substrates than C1. An enrichment of the catalase gene katG under strong positive selection was further detected in the ACB complex, conferring enhanced resistance to hydrogen peroxide. This evolutionary advantage facilitates the prevalence of the complex in clinical settings. The epidemic success of A. baumannii was further bolstered by its exceptionally high pangenome openness compared to other taxa of the complex, driving the accumulation of diverse fitness factors. In particular, the overrepresentation of an ant(3")-II gene not only confers aminoglycoside resistance, but also promotes gut colonization and systematic dissemination. Human and non-human A. baumannii strains share a highly similar genetic background, underscoring the species' robust ecological versatility.Interpretation: Our findings pinpoint fundamental drivers of phylogenetic diversification in Acinetobacter and elucidate the genomic basis propelling the emergence and success of human pathogenic species. In particular, genomic plasticity, enhanced stress adaptation, and acquisition of multifunctional fitness determinants are identified as key factors driving the ecological versatility and epidemic success of A. baumannii.

  • Open Access

    Whole-Genome-Guided Functional Characterization of Limosilactobacillus fermentum SHY0006 Reveals Hypolipidemic Activity and Improvement in Insulin Resistance 

    by Zhengyang Xu, Zihan Sun, Feiyang Wang, Qingyang Han, Shuyu Li, Chunxu Xue, Yanhui Li, Dong Liu, Jun Cai, Haiyan Sun

    Limosilactobacillus fermentum SHY0006 was isolated from Miao sour soup, a traditional fermented food from Guizhou, China, and systematically evaluated for its safety, metabolic functionality, and stress adaptability using phenotypic assays combined with whole-genome sequencing. SHY0006 exhibited no hemolytic activity and harbored no detectable virulence-associated or acquired antibiotic resistance genes, supporting its safety profile. Functionally, SHY0006 improved lipid metabolism and insulin resistance in both cell and animal models. In hyperlipidemic mice, hepatic triglyceride accumulation was markedly reduced, accompanied by favorable modulation of serum lipid parameters, including LDL-C, HDL-C, and free fatty acids. In diabetic mice, the strain improved insulin tolerance test (ITT) performance, indicating enhanced systemic insulin sensitivity. Whole-genome analysis revealed complete biosynthetic pathways for riboflavin and folate, along with extensive carbohydrate utilization capacity, highlighting its metabolic versatility. In addition, SHY0006 exhibited strong tolerance to environmental stress, supporting its potential viability in food matrices and gastrointestinal conditions. Collectively, these findings suggest that SHY0006 is a safe and metabolically versatile probiotic candidate with potential applications in functional foods targeting metabolic health.

  • Processing modulates in vitro colonic fermentation characteristics of dietary fiber from black rice bran

    by Qin Ma, Yanmei Chen, Ruifen Zhang, Fei Huang, Xuchao Jia, Shan Liang, Lihong Dong, Dong Liu, Deng Ma, Mingwei Zhang


  • Open Access

    Progress in Research on the Mechanism of GABA in Improving Sleep

    by Shuyu Li, Yanhui Li, Chunxu Xue, Ying Zhang, Tong Tong, Zijun Ouyang, Dong Liu, Jun Cai, Haiyan Sun

    Sleep disorders represent a growing global health concern with significant socio-economic impacts. GABA, a natural bioactive compound abundant in various fermented foods, especially probiotic-fermented foods, has garnered increasing attention for its potential to improve sleep quality. This review systematically elucidates the multi-pathway mechanisms by which GABA regulates sleep, focusing on (1) indirect modulation of central sleep–wake circuits via the gut–brain axis through vagal nerve, neuroendocrine, and immune pathways; (2) potential entry into the brain by leveraging the dynamic permeability of the blood–brain barrier (BBB) and transporter-mediated active transport; and (3) metabolic conversion into active substances like γ-hydroxybutyrate (GHB), which synergistically optimizes sleep architecture via multiple receptor systems and energy metabolism. Furthermore, we summarize the sleep-promoting effects of GABA-enriched foods observed in animal and clinical studies and discuss emerging applications, including high-GABA-yielding probiotics and personalized nutrition strategies for sleep intervention. This review provides a theoretical basis and innovative directions for the development of GABA-based functional foods and sleep health management.


  • Open Access

    Improvement in Physicochemical and Functional Properties of Insoluble Dietary Fiber from Rice Bran Treated with Different Processing Methods

    by Yanxia Chen, Qin Ma, Fei Huang, Xuchao Jia, Lihong Dong, Dong Liu, Mingwei Zhang, Ruifen Zhang

    Rice bran represents an exceptional natural source of dietary fiber (DF), and its physicochemical properties and therapeutic potential are closely associated with its origin and processing methods. Herein, rice bran was subjected to extrusion, fermentation, and a combined treatment of fermentation and extrusion to explore the alternations in the structural, physicochemical, and functional properties of the resulting insoluble dietary fiber (IDF). All treatments induced substantial microstructural alterations in IDF, producing fiber matrices with enhanced porosity and looser architectures. The employed processing treatments significantly enhanced the functional properties of rice bran IDF over the unprocessed sample, with 1.37- to 1.78-fold increases in oil-holding capacity, 1.31- to 1.48-fold increases in cholesterol-adsorption capacity, 2.89- to 5.90-fold increases in α-amylase-inhibitory activity, and 2.41- to 3.70-fold increases in glucose-adsorption capacity. Among them, extrusion proved more effective than fermentation in enhancing the water-holding capacity, sodium cholate binding, and cholesterol-adsorption capacity of rice bran IDF. However, fermented rice bran-derived IDF exhibited the optimum α-amylase-inhibitory and glucose-absorption capacities among all employed IDF samples. These findings provide valuable insights for the development of rice bran-based functional foods with enhanced health benefits.


  • Open Access

    Research Progress on the Mechanism of Action and Screening Methods of Probiotics for Lowering Blood Lipid Levels

    by Jingli Wang, Jieyu Chen, Mingkun Gao, Zijun Ouyang, Yanhui Li, Dong Liu, Mingjun Zhu, Haiyan Sun

    Hyperlipidemia is one of the most prevalent metabolic disorders worldwide. It is a significant risk factor for a range of cardiovascular diseases, including acute pancreatitis, fatty liver disease, atherosclerosis, and coronary heart disease. In clinical practice, the management of hyperlipidemia is hindered by numerous challenges. One of the critical issues is that traditional lipid-lowering drugs often require long-term or even lifelong administration, potentially inducing a range of adverse effects that compromise patient compliance and therapeutic efficacy. Therefore, there is an urgent need to develop safer and more effective strategies for the prevention and adjunctive treatment of hyperlipidemia with the aim of reducing the risk of disease and over-reliance on medication. Recent studies have revealed a close relationship between hyperlipidemia and related metabolic disorders involving gut microbiota dysbiosis, and the administration of probiotics has been shown to improve lipid metabolism homeostasis. This review summarizes the molecular mechanisms of probiotics in hyperlipidemia treatment and the latest advances in probiotic research on lipid metabolism, enumerates the experimental and clinical applications of probiotic-based therapies, introduces methods for screening and identifying probiotics with lipid-lowering functions, and, for the first time, summarizes the roles of emerging technologies such as functional genomics and in vivo zebrafish-on-a-chip models in studying the lipid-lowering efficacy of probiotics, providing insights for researchers. By facilitating a deeper understanding of the mechanisms whereby probiotics reduce blood lipid levels and furthering the development of multifaceted screening methods, we hope that we can achieve high-throughput and efficient screening of probiotics with lipid-lowering functions, thereby promoting the sustainable, high-quality, and rapid development of the probiotics industry.


  • Cyclic trace enzymatic hydrolysis pretreatment enhances brown rice: Cooking and taste

    by Yuanyuan Deng, Pengfei Zhou, Ya Li, Ping Li, Zhihao Zhao, Jiajia Wang, Lihuang Zhong, Guang Liu, Mingwei Zhang, Dong Liu, et al.


  • Open Access

    Jinkui Shenqi decoction targets PAD4 to restrain NETosis and ameliorates psoriasis progression

    by Wanjun Zhao, Xiaoyan Liu, Jianing Tang, Jieyu Chen, Dong Liu, Haiyan Sun, Jiao Qu, Yang Sun, Zijun Ouyang